Introducing OcuLenz
Visualising the unvisible
A revolutionary AR/XR headset for a range of uses:
- Patients with advanced macular degeneration
- Gamers and developers
- Surgeons
- Military and more
Highest resolution
Widest field-of-view
Wifi connected
Cellular connected
Acts as your smartphone
Ocutrx innovates new ways to visualize our world through AR/XR & 3D for medical, military, consumer, and enterprise.
Explore OcuLenz Capabilities
With our revolutionary technology, we are helping patients reclaim their vision across a variety of visual impairments:
- Advanced macular degeneration (AMD)
- Telemedicine
- Amblyopia
- Patient diagnosis
- Other low vision
Ocutrx is helping doctors and medical professionals improve patient care.
Ocutrx is helping developers create the next generation of AR/XR applications.
Ocutrx is helping enterprise customers improve productivity and efficiency.
Ocutrx is helping the military improve situational awareness and safety for soldiers in the field.
Introducing OcuLenz
Are you ready to take back your independence?
Pre-Order OcuLenzPre-orders will be given shipping priority over future orders, and they also come at a discount.
Are you a surgeon?
ORLenz will change the way surgeons view surgery feed and interact with patents in the operating room.
Learn More
Ocutrx Product Suite
Ready to change the world with Ocutrx?
Recent News
Ocutrx Appoints Top Neurosurgeon Dr. Robert Louis to Scientific Advisory Board, Introduces DigiLoupes™ for Brain Surgery
July 29, 2025
Read More
Ocutrx Technologies Inc. Unveils Surgery Breakthrough: First-Ever Technology to Make Blood Translucent During Surgery
June 24, 2025
Read More
OcuLenz headset showcased at CES 2024 and available for pre-order as visual aid for AMD
January 16, 2024
Read More
Please reach out for more information.
Ocutrx medical device products are being designed with the intent to improve surgeries with enhanced 3D capture and visualization. All information in this website represents the design goals of Ocutrx Technologies,Inc. and has not been evaluated by the FDA, nor granted a MDR/CE approval. These products, except for the OcuLenz for AMD (which is FDA 510(k) exempt) have not been cleared by the FDA and are not for commercial sale in the United States. These products have not yet been granted MDR/CE clearance in the UK or Europe.